Nyt ctDNA-RECIST Netværk sætter sig i spidsen for at lede et potentielt paradigmeskifte inden for onkologisk praksis. Læs mere om netværket, der ledes af @GarmSpindler på DCCC’s hjemmeside:
https://t.co/4NX1R1rRsn #SamarbejdeOmKræft#ctDNA
Two days with talks and networking at the international Multidisciplinary anal cancer conference, IMACC2023, in Rome is underway.
#analcancer#IMACC2023
A privilege on behalf of the study group to present the results from the interim feasibility analyses of the OPTIMISE study at #WCGIC2023. Looking forward to further discussion at the poster session Saturday🧬
🩸ctDNA-guided treatment in oligometastatic CRC
Christmas is the perfect time to show our appreciation to the last PhD-heroes this year: our secretaries😃👏🏻🎉 They are vital for every PhD-student and we are blessed with kind, skilled and professional secretaries at @oncaarhus☺️ Thank you for your endless help and expertise!
With over 12 presentations, @oncaarhus was well represented at the @DCCC_RT annual meeting gathering researchers in oncology and radiotherapy from all over the country. Thank you for a great and well organized meeting! #nationalcollaboration#radiotherapy
The summer has been WAY too long but September is finally here - and that means return of the monthly celebration of a PhD hero. Senior consultant @Alsner is a huge mentor and unreplaceable at @oncaarhus. He is truly our PhD hero - congratulations Jan!
@oncaarhus var flot repræsenteret på #DKFD2022, både med fantastiske oplæg af Cathrine Overgaard og @MetteNeergaard, samt 20 flotte posterpræsentationer 👏🏻 Tak for en super inspirerende konference, vi glæder os til næste år! 📚🔬
In 2021 @oncaarhus published 211 peer-reviewed papers. And 2022 kicked off brilliantly with 80 papers during the first quarter.
PhD-student @HorsholtMorten has just published a paper👏.
@HorsholtMorten investigated the precision of CT and MRI deformable image registration separated in time by months to years. This enables reliable pattern of failure analysis for identification of radio-resistant tumors in HNSCC. Read more: https://t.co/F7HS6nwGCw
I enjoyed the presentation by Francesco Sclafani at #WCGIC2022 on "Current Highlights and Future Strategies for GI". Looking forward to continue working towards bringing #ctDNA into the clinic.
https://t.co/hkRXvl84pL
@julian_hamfjord @GarmLise @myESMO
Day two at #WCGIC2022 in Barcelona. Poster presentation of Pattern of Failure in #SCCA resulting in interesting talks with fellow #analcancer enthusiasts.
@ESMOWorldGI @myESMO@oncaarhus @GarmLise